Dunn Edmund
Insider CIK 1989401 · GLUE Principal Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-03-04 | 2026-03-05 | 139 | $17.96 | $2.5K | 22,554 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-03-02 | 2026-03-02 | 536 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-03-02 | 2026-03-02 | 536 | $13.41 | $7.2K | 23,229 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-03-02 | 2026-03-02 | 536 | $17.50 | $9.4K | 22,693 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-02-27 | 2026-03-02 | 25,164 | — | $0 | 536 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-02-27 | 2026-03-02 | 25,164 | $18.10 | $455.5K | 22,693 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-02-27 | 2026-03-02 | 25,164 | $13.41 | $337.4K | 47,857 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-05 | 2026-01-05 | 1,039 | $15.17 | $15.8K | 22,693 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2025-06-03 | 2025-06-04 | 2,062 | $4.45 | $9.2K | 23,732 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-01-02 | 2025-01-06 | 53,400 | — | $0 | 53,400 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2025-01-02 | 2025-01-06 | 11,850 | — | $0 | 25,794 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-07-05 | 2024-07-09 | 1,610 | $3.83 | $6.2K | 13,944 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-06-03 | 2024-06-05 | 1,207 | $4.04 | $4.9K | 15,554 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-01-02 | 2024-01-04 | 35,900 | — | $0 | 35,900 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-01-02 | 2024-01-04 | 25,000 | — | $0 | 25,000 | SEC↗ |